IMPACT Biotech Ltd
🇮🇱Israel
- Country
- 🇮🇱Israel
- Ownership
- Private
- Established
- 2003-02-13
- Employees
- -
- Market Cap
- -
- Website
- https://impact.pub/
Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)Padeliporfin VTP Treatment for Unresectable Pancreatic Adenocarcinoma
Phase 1
Recruiting
- Conditions
- Locally Advanced Unresectable Pancreatic Adenocarcinoma
- First Posted Date
- 2023-06-26
- Last Posted Date
- 2025-02-11
- Lead Sponsor
- Impact Biotech Ltd
- Target Recruit Count
- 30
- Registration Number
- NCT05919238
- Locations
- 🇺🇸
City of Hope, Duarte, California, United States
🇺🇸University of California Irvine, Irvine, California, United States
Padeliporfin VTP Using Robotic Assisted Bronchoscopy in Peripheral Lung Cancer
Phase 1
Recruiting
- Conditions
- Peripheral Lung Tumor
- First Posted Date
- 2023-06-26
- Last Posted Date
- 2025-02-11
- Lead Sponsor
- Impact Biotech Ltd
- Target Recruit Count
- 36
- Registration Number
- NCT05918783
- Locations
- 🇺🇸
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
News
No news found